Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Neuroprotection After Cardiac Arrest
NCT02442791Completed
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of exenatide in cardiac arrest (SCA) (2 arms). Primary endpoints: Initiation of study drug infusion and Area under the Neuron-specific Enolase curve at 72 hours. Started Jun 2014; status: completed.
02
Drugs
exenatide
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02442791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442791.